Salvia miltiorrhiza (Tanshinone IIA)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Salvia miltiorrhiza (Tanshinone IIA).

Tanshinone IIA is a lipophilic diterpenoid quinone that exerts potent cardioprotective and anti-inflammatory effects primarily through the modulation of the PI3K/Akt/mTOR signaling pathway and inhibition of NF-κB activation.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

164676

Molecular Weight

294.3 g/mol

XLogP3 (Lipophilicity)

4.3

IUPAC Name

1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-10,11-dione

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Panax notoginseng saponins for synergistic enhancement of microcirculation and reduction of myocardial infarct size
Borneol for increased cerebrovascular permeability and enhanced delivery across the blood-brain barrier

Biological Formulation Enhancers

Piperine for the inhibition of P-glycoprotein-mediated efflux to increase systemic exposure
Lecithin for the creation of phytosome complexes to improve the dissolution rate of this highly lipophilic molecule

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Salvia miltiorrhiza (Tanshinone IIA) across standard consumer modalities.

💊 Standard Capsules

The extremely low aqueous solubility of Tanshinone IIA requires specialized lipid-based formulations or micronization to avoid erratic absorption when delivered in standard dry powder capsules.

🍬 Gummy & Pectin Formats

The hydrophobic nature of the molecule can lead to phase separation or crystallization, resulting in a gritty texture and non-uniform dosing within the aqueous-based gummy matrix.

🔬 Thin-Film Oral Strips

Achieving a therapeutic dose is challenging due to the low payload capacity of thin films and the requirement for complex emulsifiers to maintain stability in a polymer matrix.

For Brand Founders

Formulate with Salvia miltiorrhiza (Tanshinone IIA)

Ready to launch a product featuring Salvia miltiorrhiza (Tanshinone IIA)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Salvia miltiorrhiza (Tanshinone IIA) Bioavailability

Need absolute proof that your Salvia miltiorrhiza (Tanshinone IIA) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Salvia miltiorrhiza (Tanshinone IIA) Degradation Testing

Is your Salvia miltiorrhiza (Tanshinone IIA) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation